Flamant, Mathurin <br/><br/>
Could therapeutic drug monitoring of anti-TNF-α be useful to consider a de-escalation of treatment?  [electronic resource] 

 -  Expert opinion on biological therapy  2015 
 - 1657-60 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1744-7682 
<br/><br/><label>Standard No.: </label>10.1517/14712598.2015.1069273  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Azathioprine--metabolism<br/>Drug Monitoring<br/>Humans<br/>Immunologic Factors--metabolism<br/>Inflammatory Bowel Diseases--drug therapy<br/>Infliximab--metabolism<br/>Recurrence<br/>Tumor Necrosis Factor-alpha--immunology